Annual SGA
$6.26 M
-$5.56 M-47.04%
December 1, 2024
Summary
- As of March 10, 2025, VRPX annual SGA is $6.26 million, with the most recent change of -$5.56 million (-47.04%) on December 1, 2024.
- During the last 3 years, VRPX annual SGA has fallen by -$925.80 thousand (-12.88%).
- VRPX annual SGA is now -47.04% below its all-time high of $11.82 million, reached on December 31, 2023.
Performance
VRPX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.29 M
+$1.51 M+192.98%
December 1, 2024
Summary
- As of March 10, 2025, VRPX quarterly SGA is $2.29 million, with the most recent change of +$1.51 million (+192.98%) on December 1, 2024.
- Over the past year, VRPX quarterly SGA has stayed the same.
- VRPX quarterly SGA is now -53.40% below its all-time high of $4.91 million, reached on September 30, 2022.
Performance
VRPX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$268.81 M
-$12.07 M-4.70%
December 1, 2024
Summary
- As of March 10, 2025, VRPX TTM SGA is -$268.81 million, with the most recent change of -$12.07 million (-4.70%) on December 1, 2024.
- Over the past year, VRPX TTM SGA has dropped by -$275.07 million (-4393.64%).
- VRPX TTM SGA is now -4161.31% below its all-time high of -$6.31 million.
Performance
VRPX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VRPX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.0% | 0.0% | -4393.6% |
| 3 y3 years | -12.9% | -3.5% | -3840.5% |
| 5 y5 years | +144.6% | +47.5% | -5080.9% |
VRPX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.0% | at low | -53.4% | +450.7% | -285.7% | at low |
| 5 y | 5-year | -47.0% | +144.6% | -53.4% | +450.7% | -1554.2% | at low |
| alltime | all time | -47.0% | +321.9% | -53.4% | +450.7% | -4161.3% | at low |
Virpax Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $6.26 M(-47.0%) | $2.29 M(+193.0%) | $6.26 M(-28.9%) |
| Sep 2024 | - | $781.00 K(-48.0%) | $8.81 M(-30.3%) |
| Jun 2024 | - | $1.50 M(-11.1%) | $12.65 M(-3.4%) |
| Mar 2024 | - | $1.69 M(-65.1%) | $13.10 M(+10.8%) |
| Dec 2023 | $11.82 M(+6.7%) | $4.84 M(+4.7%) | $11.82 M(+35.4%) |
| Sep 2023 | - | $4.62 M(+137.1%) | $8.73 M(-3.2%) |
| Jun 2023 | - | $1.95 M(+369.0%) | $9.02 M(-7.2%) |
| Mar 2023 | - | $415.50 K(-76.2%) | $9.72 M(-12.3%) |
| Dec 2022 | $11.08 M | $1.74 M(-64.5%) | $11.08 M(-5.4%) |
| Sep 2022 | - | $4.91 M(+85.6%) | $11.71 M(+40.2%) |
| Jun 2022 | - | $2.65 M(+48.4%) | $8.35 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.78 M(-24.9%) | $7.70 M(+7.1%) |
| Dec 2021 | $7.19 M(+147.5%) | $2.37 M(+52.9%) | $7.19 M(+33.2%) |
| Sep 2021 | - | $1.55 M(-22.0%) | $5.40 M(+15.9%) |
| Jun 2021 | - | $1.99 M(+56.2%) | $4.66 M(+24.9%) |
| Mar 2021 | - | $1.27 M(+118.6%) | $3.73 M(+28.4%) |
| Dec 2020 | $2.90 M(+13.5%) | $582.60 K(-28.1%) | $2.90 M(+2.6%) |
| Sep 2020 | - | $810.70 K(-23.6%) | $2.83 M(+40.1%) |
| Jun 2020 | - | $1.06 M(+136.5%) | $2.02 M(+110.8%) |
| Mar 2020 | - | $449.00 K(-11.8%) | $957.90 K(+88.2%) |
| Dec 2019 | $2.56 M(+72.5%) | $508.90 K | $508.90 K |
| Dec 2018 | $1.48 M | - | - |
FAQ
- What is Virpax Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual SGA year-on-year change?
- What is Virpax Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly SGA year-on-year change?
- What is Virpax Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals TTM SGA year-on-year change?
What is Virpax Pharmaceuticals annual SGA?
The current annual SGA of VRPX is $6.26 M
What is the all time high annual SGA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual SGA is $11.82 M
What is Virpax Pharmaceuticals annual SGA year-on-year change?
Over the past year, VRPX annual SGA has changed by -$5.56 M (-47.04%)
What is Virpax Pharmaceuticals quarterly SGA?
The current quarterly SGA of VRPX is $2.29 M
What is the all time high quarterly SGA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly SGA is $4.91 M
What is Virpax Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, VRPX quarterly SGA has changed by $0.00 (0.00%)
What is Virpax Pharmaceuticals TTM SGA?
The current TTM SGA of VRPX is -$268.81 M
What is the all time high TTM SGA for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high TTM SGA is -$6.31 M
What is Virpax Pharmaceuticals TTM SGA year-on-year change?
Over the past year, VRPX TTM SGA has changed by -$275.07 M (-4393.64%)